Innate Pharma
IPHA
#8749
Rank
C$0.34 B
Marketcap
C$3.09
Share price
3.24%
Change (1 day)
7.00%
Change (1 year)

Annual Reports (20-F)

Latest form 20-F annual reports for Innate Pharma CIK: 0001598599
The 20-F is a 10-K equivalent for non-US companies, as a foreight company Innate Pharma only files 20-F reports

Thumbnail Innate Pharma
 20-F Annual Report 2025

20-F Annual Report 2025

Language: English

View Annual Report (20-F)
Thumbnail Innate Pharma
 20-F Annual Report 2024

20-F Annual Report 2024

Language: English

View Annual Report (20-F)
Thumbnail Innate Pharma
 20-F Annual Report 2023

20-F Annual Report 2023

Language: English

View Annual Report (20-F)
Thumbnail Innate Pharma
 20-F Annual Report 2022

20-F Annual Report 2022

Language: English

View Annual Report (20-F)
Thumbnail Innate Pharma
 20-F Annual Report 2021

20-F Annual Report 2021

Language: English

View Annual Report (20-F)
Thumbnail Innate Pharma
 20-F Annual Report 2020

20-F Annual Report 2020

Language: English

View Annual Report (20-F)
Thumbnail Innate Pharma
 20-F Annual Report 2019

20-F Annual Report 2019

Language: English

View Annual Report (20-F)